Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

BUY
$4.35 - $15.85 $375,535 - $1.37 Million
86,330 New
86,330 $976,000
Q1 2022

May 16, 2022

SELL
$4.55 - $6.41 $64,710 - $91,163
-14,222 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$5.89 - $9.73 $292,173 - $482,656
-49,605 Reduced 77.72%
14,222 $84,000
Q3 2021

Nov 15, 2021

BUY
$6.78 - $9.89 $243,300 - $354,902
35,885 Added 128.43%
63,827 $544,000
Q2 2021

Aug 16, 2021

BUY
$7.24 - $11.2 $202,300 - $312,950
27,942 New
27,942 $225,000
Q1 2020

May 15, 2020

SELL
$2.58 - $4.58 $96,706 - $171,672
-37,483 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$1.86 - $3.35 $69,718 - $125,568
37,483 New
37,483 $126,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $56.9M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.